Trastuzumab-Modified Gold Nanoparticles Labeled with (211)At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer

Highly localized radiotherapy with radionuclides is a commonly used treatment modality for patients with unresectable solid tumors. Herein, we propose a novel α-nanobrachytherapy approach for selective therapy of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. This uses local...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziawer, Łucja, Majkowska-Pilip, Agnieszka, Gaweł, Damian, Godlewska, Marlena, Pruszyński, Marek, Jastrzębski, Jerzy, Wąs, Bogdan, Bilewicz, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523862/
https://www.ncbi.nlm.nih.gov/pubmed/31003512
http://dx.doi.org/10.3390/nano9040632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523862/
https://www.ncbi.nlm.nih.gov/pubmed/31003512
http://dx.doi.org/10.3390/nano9040632

Ejemplares similares